Common Stock, par value $.01 per share
- Symbol
- IEX
- Exchange
- NYSE
- Classification
- COMMON
- Status
- Current
Current Report · Items 2.02, 9.01 · 8-K
IDEX Corporation
IEXNYSEEQUITYCurrent
Results of Operations and Financial Condition
Item 2.02 – Results of Operations and Financial Condition. On April 29, 2026, IDEX Corporation (the “Company”) issued a press release announcing financial results for the period ended March 31, 2026. A copy of the press release is furnished as Exhibit 99.1 to this report.…
Company context
IDEX Corporation (NYSE: IEX), a global engineered products company, is comprised of three primary business segments - Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety/Diversified Products. Thousands of IDEX employees around the world design and manufacture highly engineered components and applied solutions that are vital to the advances of modern life and help IDEX live its purpose - Trusted Solutions, Improving Lives™. From satellite communications to water systems, from medical diagnostic components to emergency rescue tools and more, we collaborate with customers in the most critical industries to develop solutions that make the world better today and into the future. Founded in 1988, IDEX now includes more than 50 dynamic businesses around the world and manufacturing operations in more than 20 countries.
Current securities
Registered securities in this filing
IDEX CORP · 8-K · Filed 2026-04-29
Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Item 2.02 – Results of Operations and Financial Condition.
On April 29, 2026, IDEX Corporation (the “Company”) issued a press release announcing financial results for the period ended March 31, 2026. A copy of the press release is furnished as Exhibit 99.1 to this report.
The information contained in this Item 2.02 (including Exhibit 99.1 attached hereto) is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Filed exhibits (1)
EX-99.1 2 iex-20260331xex991.htm EX-99.1 Document For further information: TRADED: NYSE (IEX) EX-99.1 Investor Contact: Jim Giannakouros, CFA Vice President, Investor Relations (847) 313-9506 IDEX REPORTS FIRST QUARTER RESULTS Highlights (All comparisons are against the prior year period unless otherwise noted) • Sales of $887 million increased 9% on a reported basis and 5% organically • Reported diluted EPS of $1.61 increased 28% and adjusted diluted EPS of $2.00 increased 14% • Record orders of $988 million increased 13% on a reported basis and increased 10% organically • Returned capital to shareholders via $76 million of share repurchases and $53 million of dividends • Raising full year 2026 organic growth and adjusted EPS guidance ranges NORTHBROOK, IL, April 29, 2026 - IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended March 31, 2026. “We delivered a strong first quarter, with results ahead of our expectations led by continued momentum in our growth platforms within our Health & Science Technologies segment,” said Eric D. Ashleman, IDEX Corporation Chief Executive Officer and President. “Our first quarter re…
Open exhibit ↗